Cargando…

Changes in body composition and metabolic profile during interleukin 6 inhibition in rheumatoid arthritis

BACKGROUND: Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by increased mortality associated with cardiometabolic disorders including dyslipidaemia, insulin resistance, and cachectic obesity. Tumour necrosis factor inhibitors and interleukin 6 receptor blocker licensed for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tournadre, Anne, Pereira, Bruno, Dutheil, Fréderic, Giraud, Charlotte, Courteix, Daniel, Sapin, Vincent, Frayssac, Thomas, Mathieu, Sylvain, Malochet‐Guinamand, Sandrine, Soubrier, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566648/ https://www.ncbi.nlm.nih.gov/pubmed/28316139 http://dx.doi.org/10.1002/jcsm.12189

Ejemplares similares

The Effect of TNF and Non-TNF-Targeted Biologics on Body Composition in Rheumatoid Arthritis
por: Vial, Gaelle, et al.
Publicado: (2021)

Retention rates of adalimumab, etanercept, and infliximab as first‐ or second‐line biotherapies for spondyloarthritis patients in daily practice in Auvergne (France)
por: Soubrier, Martin, et al.
Publicado: (2018)

Glucocorticoid trajectories over 2 years in patients with rheumatoid arthritis in a real-life setting
por: Delteil, Alycia, et al.
Publicado: (2023)

Assessment of Intramuscular Fat and Correlation with Body Composition in Patients with Rheumatoid Arthritis and Spondyloarthritis: A Pilot Study
por: Villedon de Naide, Marc, et al.
Publicado: (2021)

Construction and utilization of a script concordance test as an assessment tool for dcem3 (5th year) medical students in rheumatology
por: Mathieu, Sylvain, et al.
Publicado: (2013)

Prevalence of Migraine and Neuropathic Pain in Rheumatic Diseases
por: Mathieu, Sylvain, et al.
Publicado: (2020)

Prevalence and risk factors of low bone mineral density in spondyloarthritis and prevalence of vertebral fractures
por: Malochet-Guinamand, Sandrine, et al.
Publicado: (2017)

Refractory Rheumatic Disorder: Atypical Postpregnancy Osteoporosis
por: Mourgues, Cindy, et al.
Publicado: (2015)

Omega 3 Fatty Acids Intake Does Not Decrease the Risk of Rheumatoid Arthritis Occurrence: A Meta-Analysis. Comment on Tański et al. The Relationship between Fatty Acids and the Development, Course and Treatment of Rheumatoid Arthritis. Nutrients 2022, 14, 1030
por: Mathieu, Sylvain, et al.
Publicado: (2023)

Effects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis
por: Mathieu, Sylvain, et al.
Publicado: (2013)

Efficacy and safety of pamidronate in Modic type 1 changes: study protocol for a prospective randomized controlled clinical trial
por: Cecchetti, Stella, et al.
Publicado: (2014)

Treatment of Metabolic syndrome by combination of physical activity and diet needs an optimal protein intake: a randomized controlled trial
por: Dutheil, Frédéric, et al.
Publicado: (2012)

Agranulocytosis under biotherapy in rheumatoid arthritis: three cases hypothesis of parvovirus B19 involvement in agranulocytosis observed under tocilizumab and rituximab for the treatment of rheumatoid arthritis
por: Giraud, C., et al.
Publicado: (2016)

Could Omega 3 Fatty Acids Preserve Muscle Health in Rheumatoid Arthritis?
por: Lanchais, Kassandra, et al.
Publicado: (2020)

Body composition in patients with rheumatoid arthritis: a narrative literature review
por: Letarouilly, Jean-Guillaume, et al.
Publicado: (2021)

Does rheumatoid synovitis activity vary during the day? Evaluation with color doppler sonography
por: Lazaar, Hakim, et al.
Publicado: (2017)

Response to 'Statins accelerate the onset of collagen type II-induced arthritis in mice'
por: Mathieu, Sylvain, et al.
Publicado: (2013)

A Meta-Analysis of the Impact of Nutritional Supplementation on Osteoarthritis Symptoms
por: Mathieu, Sylvain, et al.
Publicado: (2022)

Interleukin 6 and Rheumatoid Arthritis
por: Yoshida, Yuji, et al.
Publicado: (2014)

Interleukin-6 in Rheumatoid Arthritis
por: Pandolfi, Franco, et al.
Publicado: (2020)

Cross-sectional and longitudinal study protocols of the ‘ADIposity and BOne metabolism: effects of eXercise-induced weight loss in obese adolescents’ (ADIBOX) project
por: Chaplais, Elodie, et al.
Publicado: (2016)

Atherogenic subfractions of lipoproteins in the treatment of metabolic syndrome by physical activity and diet – the RESOLVE trial
por: Dutheil, Frédéric, et al.
Publicado: (2014)

Interleukin-7 deficiency in rheumatoid arthritis
por: Leonard, Warren J
Publicado: (2005)

Impact of gender on the response and tolerance to abatacept in patients with rheumatoid arthritis: results from the ‘ORA’ registry
por: Nourisson, Cynthia, et al.
Publicado: (2017)

Survey of adolescents’ needs and parents’ views on sexual health in juvenile idiopathic arthritis
por: Savel, Carine, et al.
Publicado: (2023)

Blood lipids and adipokines concentrations during a 6-month nutritional and physical activity intervention for metabolic syndrome treatment
por: Dutheil, Frédéric, et al.
Publicado: (2010)

Long-term cost reduction of routine medications following a residential programme combining physical activity and nutrition in the treatment of type 2 diabetes: a prospective cohort study
por: Lanhers, Charlotte, et al.
Publicado: (2017)

Immunoregulatory role of interleukin 10 in rheumatoid arthritis
Publicado: (1994)

Interleukin-6 inhibitors in the treatment of rheumatoid arthritis
por: Hennigan, Stephanie, et al.
Publicado: (2008)

The Roles of Interleukin-6 in the Pathogenesis of Rheumatoid Arthritis
por: Hashizume, Misato, et al.
Publicado: (2011)

Interleukin-17 in rheumatoid arthritis: Trials and tribulations
por: Taams, Leonie S.
Publicado: (2020)

Interleukin-9 Facilitates Osteoclastogenesis in Rheumatoid Arthritis
por: Kar, Santanu, et al.
Publicado: (2021)

Pathogenesis and Function of Interleukin-35 in Rheumatoid Arthritis
por: Xin, Pan Lin, et al.
Publicado: (2021)

Modulation of peripheral T-cell function by interleukin-7 in rheumatoid arthritis
por: Churchman, Sarah M, et al.
Publicado: (2014)

Characteristics of spontaneous coagulase-negative staphylococcal spondylodiscitis: a retrospective comparative study versus Staphylococcus aureus spondylodiscitis
por: Lopez, Julien, et al.
Publicado: (2017)

Effect of Filgotinib on Body Mass Index (BMI) and Effect of Baseline BMI on the Efficacy and Safety of Filgotinib in Rheumatoid Arthritis
por: Balsa, Alejandro, et al.
Publicado: (2023)

Interleukin-18: a therapeutic target in rheumatoid arthritis?
por: McInnes, Iain B, et al.
Publicado: (2005)

Interleukin-6 receptor in the recent-onset rheumatoid arthritis
por: Montes-Cano, Marco Antonio, et al.
Publicado: (2011)

Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor
por: Dayer, Jean-Michel, et al.
Publicado: (2010)

Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis
por: Choy, Ernest H S, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_90shiq665c4602rlr87monhevu